79747-2
Reese-Ellsworth Extraocular retinoblastoma classification at final disease stage Right eye
Active
Term Description
This term was developed in collaboration with the National Institute of Health's National Eye Institute (NEI) as part of an effort to standardize the data elements collected by the National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE).
Source: Regenstrief LOINC
Part Descriptions
LP201235-1 Extraocular retinoblastoma classification
The Reese-Ellsworth extraocular retinoblastoma staging system applies to cancer that has spread outside of the eye, either to the tissues around the eye or to the central nervous system (CNS), bone marrow, or lymph nodes. This staging system is based on how much cancer remains after surgery to remove the tumor and whether the cancer has spread. Details of each stage in the extraocular staging system are as follows:
Stage 0 (zero) - the cancer is in the eye (called intraocular) and has not spread outside of the eye. Most retinoblastoma cases are discovered in Stage 0 and should be classified based on the International Classification for Intraocular Retinoblastoma (ICRB). Doctors recommend conservative treatment for this stage with no additional adjuvant therapy, meaning no additional treatment after surgery.
Stage I - the eye has already been removed and there is some microscopic spread to the optic nerve. These patients need adjuvant chemotherapy after surgery.
Stage II - the tumor has spread to the optic nerve or the sclera, which is the white part of the eye. Patients with this stage need adjuvant chemotherapy and possibly radiation therapy.
Stage III - the cancer has spread to the lymph nodes or the bony cavity that surrounds the eyeball. Stage III is divided into two substages called stage IIIa and stage IIIb, depending on where the tumor has spread. The treatment for this stage involves both chemotherapy and radiation therapy.
Stage IV - the tumor has spread to distant areas of the body outside the eye, via the lymphatic system and blood vessels. Stage IV is divided into substages called IVa and IVb, and IVb is further divided into IVb1, IVb2, and IVb3, depending on the location of the spread. This stage of extraocular retinoblastoma is treated with high-dose chemotherapy followed by stem cell rescue. Radiation therapy may also be used in addition to high-dose chemotherapy for some patients with stage IV disease.
[http://www.cancer.gov/types/retinoblastoma/patient/retinoblastoma-treatment-pdq#link/stoc_h2_1]
Source: National Cancer Institute,
LP203649-1 EYE.HX.NEI
Developed in collaboration with the National Institute of Health's National Eye Institute (NEI) as part of an effort to standardize the data elements collected by the National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE).
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Extraocular retinoblastoma classification^at final disease stage
- Property
- Class
- Time
- Pt
- System
- Eye.right
- Scale
- Ord
- Method
- Reese-Ellsworth system
Additional Names
- Short Name
- Reese-Ells class final dis stage Eye-R
Normative Answer List: LL3733-4
Source: National Eye InstituteAnswer | Code | Score | Answer ID |
---|---|---|---|
Stage 0 | 0 | LA4323-7 | |
Stage I Stage I means that eye has already been removed and there is some microscopic spread to the optic nerve. These patients need adjuvant chemotherapy after surgery. |
1 | LA3664-5 | |
Stage II Stage II means that the tumor has spread to the optic nerve or the sclera, which is the white part of the eye. Patients with this stage need adjuvant chemotherapy and possibly radiation therapy. |
2 | LA3661-1 | |
Stage III means that the cancer has spread to the lymph nodes or the bony cavity that surrounds the eyeball. It is divided into two substages called stage IIIa and stage IIIb, depending on where the tumor has spread. The treatment for this stage involves both chemotherapy and radiation therapy. |
3 | LA3657-9 | |
Stage IV In stage IV, the tumor has spread to distant areas of the body outside the eye, via the lymphatic system and blood vessels. Stage IV is divided into substages of IVa and IVb. Stage IVb is further divided into IVb1, IVb2, and IVb3, depending on the location of the spread. This stage of extraocular retinoblastoma is treated with high-dose chemotherapy followed by stem cell rescue. |
4 | LA3651-2 | |
UnknownCopyright http://snomed.info/sct ID:261665006 Unknown (qualifier value) | UNK | LA4489-6 |
Basic Attributes
- Class
- EYE.HX.NEI
- Type
- Clinical
- First Released
- Version 2.54
- Last Updated
- Version 2.54
- Order vs. Observation
- Observation
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Clasificación del retinoblastoma extraocular ^ en la etapa final de la enfermedad: |
it-IT | Italian (Italy) | Classificazione del retinoblastoma extraoculare^allo stadio finale di malattia: Synonyms: Concetti storia NEI eyeGENE Fase Occhio Occhio Destro Punto nel tempo (episodio) Sistema Reese-Ellsworth; |
zh-CN | Chinese (China) | 眼外视网膜母细胞瘤分类^最终疾病分期时: Synonyms: R Reese-Ellsworth 分期系统; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=79747-2
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright